Cargando…
Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation
BACKGROUND: Rapamycin (Rapa), acarbose (ACA), and 17α-estradiol (17aE2, males only) have health benefits that increase lifespan of mice. Little is known about how these three agents alter the network of pathways downstream of insulin/IGF1 signals as well as inflammatory/stress responses. RESULTS: AC...
Autores principales: | Wink, Lily, Miller, Richard A., Garcia, Gonzalo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805398/ https://www.ncbi.nlm.nih.gov/pubmed/35105357 http://dx.doi.org/10.1186/s12979-022-00264-1 |
Ejemplares similares
-
Cap‐independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α‐estradiol
por: Shen, Ziqian, et al.
Publicado: (2021) -
Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
por: Harrison, David E, et al.
Publicado: (2014) -
Sex differences in lifespan extension with acarbose and 17‐α estradiol: gonadal hormones underlie male‐specific improvements in glucose tolerance and mTORC2 signaling
por: Garratt, Michael, et al.
Publicado: (2017) -
Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
por: Strong, Randy, et al.
Publicado: (2022) -
Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset
por: Fernandez, Elizabeth, et al.
Publicado: (2019)